Crawford Investment Counsel’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-66,933
Closed -$1.19M 254
2016
Q4
$1.19M Sell
66,933
-290
-0.4% -$5.09K 0.04% 155
2016
Q3
$1.3M Sell
67,223
-13,917
-17% -$272K 0.05% 155
2016
Q2
$1.58M Buy
81,140
+6,500
+9% +$127K 0.06% 125
2016
Q1
$1.54M Sell
74,640
-11,140
-13% -$220K 0.06% 122
2015
Q4
$1.76M Sell
85,780
-9,670
-10% -$185K 0.08% 102
2015
Q3
$1.63M Sell
95,450
-68,800
-42% -$1.26M 0.07% 116
2015
Q2
$3.06M Sell
164,250
-93,970
-36% -$1.74M 0.12% 86
2015
Q1
$4.93M Sell
258,220
-282,830
-52% -$5.23M 0.18% 72
2014
Q4
$8.91M Sell
541,050
-15,541
-3% -$267K 0.31% 45
2014
Q3
$9.85M Buy
556,591
+123,951
+29% +$2.44M 0.36% 40
2014
Q2
$8.93M Buy
432,640
+62,530
+17% +$1.28M 0.32% 42
2014
Q1
$8.06M Buy
370,110
+310,180
+518% +$7.11M 0.29% 45
2013
Q4
$1.59M Buy
59,930
+20,580
+52% +$506K 0.06% 91
2013
Q3
$930K Buy
39,350
+13,240
+51% +$309K 0.04% 108
2013
Q2
$561K Buy
+26,110
New +$563K 0.02% 138

Other funds holding VIVO

Crawford Investment Counsel's VIVO Position: Q1 2017 in Review

Crawford Investment Counsel sold out of Meridian Bioscience Inc (VIVO) in Q1 2017, closing a stake of 66,933 shares — an estimated $1.19M sold.

Crawford Investment Counsel first reported a position in VIVO in Q2 2013 and held it in 15 quarters. The position peaked at $9.85M in Q3 2014. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

  • Crawford Investment Counsel reported no remaining Meridian Bioscience Inc position as of Q1 2017 after selling out during the quarter.
  • Crawford Investment Counsel sold 66,933 Meridian Bioscience Inc shares in Q1 2017, an estimated $1.19M.
  • Crawford Investment Counsel first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 15 quarters.
  • Crawford Investment Counsel's Meridian Bioscience Inc position peaked at $9.85M in Q3 2014.
  • 165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on Crawford Investment Counsel's 13F filing for Q1 2017, filed 4 May 2017.